Sen. Tillis Asks Biden Administration to Oppose WTO Waiver Proposal

Publication Date22 April 2021
SubjectWTO,Life Sciences,Biotechnology,Biosimilars,TRIPS Agreement,Pharmaceutical Industry,Coronavirus/COVID-19,Biden Administration
AuthorDonald Zuhn
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT